nodes	percent_of_prediction	percent_of_DWPC	metapath
Testolactone—Progesterone—uterine cancer	0.418	1	CrCtD
Testolactone—CYP19A1—uterine cancer	0.247	1	CbGaD
Testolactone—Drospirenone—Medroxyprogesterone Acetate—uterine cancer	0.0221	0.0735	CrCrCtD
Testolactone—Dydrogesterone—Medroxyprogesterone Acetate—uterine cancer	0.0221	0.0735	CrCrCtD
Testolactone—Spironolactone—Medroxyprogesterone Acetate—uterine cancer	0.0211	0.07	CrCrCtD
Testolactone—Formestane—Progesterone—uterine cancer	0.0203	0.0675	CrCrCtD
Testolactone—Dydrogesterone—Progesterone—uterine cancer	0.0193	0.0641	CrCrCtD
Testolactone—Drospirenone—Progesterone—uterine cancer	0.0193	0.0641	CrCrCtD
Testolactone—Spironolactone—Progesterone—uterine cancer	0.0184	0.061	CrCrCtD
Testolactone—Danazol—Progesterone—uterine cancer	0.0155	0.0515	CrCrCtD
Testolactone—Prednicarbate—Medroxyprogesterone Acetate—uterine cancer	0.0146	0.0483	CrCrCtD
Testolactone—Fluoxymesterone—Medroxyprogesterone Acetate—uterine cancer	0.0134	0.0444	CrCrCtD
Testolactone—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.013	0.0433	CrCrCtD
Testolactone—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.013	0.0433	CrCrCtD
Testolactone—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.0127	0.0422	CrCrCtD
Testolactone—Fluoxymesterone—Progesterone—uterine cancer	0.0117	0.0387	CrCrCtD
Testolactone—Testosterone Propionate—Progesterone—uterine cancer	0.0114	0.0377	CrCrCtD
Testolactone—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.0113	0.0376	CrCrCtD
Testolactone—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.0113	0.0376	CrCrCtD
Testolactone—Methyltestosterone—Progesterone—uterine cancer	0.0111	0.0368	CrCrCtD
Testolactone—Testosterone—Progesterone—uterine cancer	0.00987	0.0328	CrCrCtD
Testolactone—CYP19A1—corpus luteum—uterine cancer	0.00976	0.563	CbGeAlD
Testolactone—Prednisolone—Progesterone—uterine cancer	0.00966	0.0321	CrCrCtD
Testolactone—CYP19A1—semen—uterine cancer	0.00457	0.264	CbGeAlD
Testolactone—CYP19A1—endometrium—uterine cancer	0.000756	0.0435	CbGeAlD
Testolactone—CYP19A1—uterus—uterine cancer	0.000696	0.0401	CbGeAlD
Testolactone—CYP19A1—female reproductive system—uterine cancer	0.000626	0.0361	CbGeAlD
Testolactone—CYP19A1—female gonad—uterine cancer	0.00057	0.0328	CbGeAlD
Testolactone—CYP19A1—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.00054	0.119	CbGpPWpGaD
Testolactone—Blood pressure increased—Progesterone—uterine cancer	0.000536	0.0543	CcSEcCtD
Testolactone—Blood pressure increased—Medroxyprogesterone Acetate—uterine cancer	0.000486	0.0492	CcSEcCtD
Testolactone—CYP19A1—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.00039	0.0859	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.00039	0.0859	CbGpPWpGaD
Testolactone—CYP19A1—lymph node—uterine cancer	0.000366	0.0211	CbGeAlD
Testolactone—CYP19A1—Endogenous sterols—CYP11A1—uterine cancer	0.000312	0.0686	CbGpPWpGaD
Testolactone—Dydrogesterone—PGR—uterine cancer	0.000312	0.146	CrCbGaD
Testolactone—Pain—Carboplatin—uterine cancer	0.000311	0.0316	CcSEcCtD
Testolactone—Alopecia—Progesterone—uterine cancer	0.000238	0.0241	CcSEcCtD
Testolactone—Erythema—Progesterone—uterine cancer	0.000234	0.0238	CcSEcCtD
Testolactone—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.000234	0.0514	CbGpPWpGaD
Testolactone—CYP19A1—Ovarian Infertility Genes—MLH1—uterine cancer	0.000232	0.0511	CbGpPWpGaD
Testolactone—CYP19A1—Ovarian Infertility Genes—PGR—uterine cancer	0.00022	0.0485	CbGpPWpGaD
Testolactone—Ill-defined disorder—Progesterone—uterine cancer	0.000217	0.022	CcSEcCtD
Testolactone—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000216	0.0218	CcSEcCtD
Testolactone—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000212	0.0215	CcSEcCtD
Testolactone—Malaise—Progesterone—uterine cancer	0.000211	0.0214	CcSEcCtD
Testolactone—Danazol—CCL2—uterine cancer	0.0002	0.0936	CrCbGaD
Testolactone—Discomfort—Progesterone—uterine cancer	0.000197	0.02	CcSEcCtD
Testolactone—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000197	0.02	CcSEcCtD
Testolactone—CYP19A1—Ovarian Infertility Genes—ESR2—uterine cancer	0.000194	0.0427	CbGpPWpGaD
Testolactone—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000192	0.0194	CcSEcCtD
Testolactone—Oedema—Progesterone—uterine cancer	0.000191	0.0194	CcSEcCtD
Testolactone—Anorexia—Progesterone—uterine cancer	0.000182	0.0185	CcSEcCtD
Testolactone—Exemestane—CYP19A1—uterine cancer	0.000182	0.0852	CrCbGaD
Testolactone—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000179	0.0181	CcSEcCtD
Testolactone—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000173	0.0176	CcSEcCtD
Testolactone—Paraesthesia—Progesterone—uterine cancer	0.000172	0.0174	CcSEcCtD
Testolactone—Alopecia—Dactinomycin—uterine cancer	0.000168	0.017	CcSEcCtD
Testolactone—Glossitis—Epirubicin—uterine cancer	0.000167	0.0169	CcSEcCtD
Testolactone—Decreased appetite—Progesterone—uterine cancer	0.000166	0.0169	CcSEcCtD
Testolactone—Erythema—Dactinomycin—uterine cancer	0.000166	0.0168	CcSEcCtD
Testolactone—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000165	0.0167	CcSEcCtD
Testolactone—Drospirenone—PGR—uterine cancer	0.000164	0.0767	CrCbGaD
Testolactone—Pain—Progesterone—uterine cancer	0.000164	0.0166	CcSEcCtD
Testolactone—Feeling abnormal—Progesterone—uterine cancer	0.000158	0.016	CcSEcCtD
Testolactone—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000156	0.0158	CcSEcCtD
Testolactone—Glossitis—Doxorubicin—uterine cancer	0.000154	0.0156	CcSEcCtD
Testolactone—Ill-defined disorder—Dactinomycin—uterine cancer	0.000154	0.0156	CcSEcCtD
Testolactone—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000151	0.0153	CcSEcCtD
Testolactone—Malaise—Dactinomycin—uterine cancer	0.000149	0.0151	CcSEcCtD
Testolactone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000145	0.0319	CbGpPWpGaD
Testolactone—CYP19A1—Ovarian Infertility Genes—SMAD3—uterine cancer	0.000144	0.0317	CbGpPWpGaD
Testolactone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000143	0.0145	CcSEcCtD
Testolactone—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000143	0.0314	CbGpPWpGaD
Testolactone—Discomfort—Dactinomycin—uterine cancer	0.000139	0.0141	CcSEcCtD
Testolactone—Oedema—Dactinomycin—uterine cancer	0.000135	0.0137	CcSEcCtD
Testolactone—Anorexia—Dactinomycin—uterine cancer	0.000129	0.0131	CcSEcCtD
Testolactone—Alopecia—Etoposide—uterine cancer	0.000122	0.0123	CcSEcCtD
Testolactone—Danazol—PGR—uterine cancer	0.000122	0.057	CrCbGaD
Testolactone—Vomiting—Progesterone—uterine cancer	0.000122	0.0123	CcSEcCtD
Testolactone—Decreased appetite—Dactinomycin—uterine cancer	0.000118	0.0119	CcSEcCtD
Testolactone—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000117	0.0258	CbGpPWpGaD
Testolactone—Spironolactone—PGR—uterine cancer	0.000117	0.0546	CrCbGaD
Testolactone—Pain—Dactinomycin—uterine cancer	0.000116	0.0117	CcSEcCtD
Testolactone—Nausea—Progesterone—uterine cancer	0.000114	0.0115	CcSEcCtD
Testolactone—Feeling abnormal—Dactinomycin—uterine cancer	0.000111	0.0113	CcSEcCtD
Testolactone—Ill-defined disorder—Etoposide—uterine cancer	0.000111	0.0113	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000111	0.0243	CbGpPWpGaD
Testolactone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00011	0.0112	CcSEcCtD
Testolactone—Malaise—Etoposide—uterine cancer	0.000108	0.011	CcSEcCtD
Testolactone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000103	0.0104	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000103	0.0226	CbGpPWpGaD
Testolactone—Discomfort—Etoposide—uterine cancer	0.000101	0.0102	CcSEcCtD
Testolactone—Estrone—ESR2—uterine cancer	0.0001	0.0471	CrCbGaD
Testolactone—Betamethasone—PGR—uterine cancer	9.92e-05	0.0465	CrCbGaD
Testolactone—Anorexia—Etoposide—uterine cancer	9.33e-05	0.00945	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	9.18e-05	0.0202	CbGpPWpGaD
Testolactone—Paraesthesia—Etoposide—uterine cancer	8.79e-05	0.0089	CcSEcCtD
Testolactone—Vomiting—Dactinomycin—uterine cancer	8.6e-05	0.00871	CcSEcCtD
Testolactone—Decreased appetite—Etoposide—uterine cancer	8.51e-05	0.00862	CcSEcCtD
Testolactone—Pain—Etoposide—uterine cancer	8.37e-05	0.00848	CcSEcCtD
Testolactone—Danazol—CYP19A1—uterine cancer	8.34e-05	0.0391	CrCbGaD
Testolactone—Feeling abnormal—Etoposide—uterine cancer	8.06e-05	0.00817	CcSEcCtD
Testolactone—Fluoxymesterone—ESR1—uterine cancer	8.04e-05	0.0377	CrCbGaD
Testolactone—Nausea—Dactinomycin—uterine cancer	8.03e-05	0.00814	CcSEcCtD
Testolactone—CYP19A1—Ovarian Infertility Genes—CDKN1B—uterine cancer	7.99e-05	0.0176	CbGpPWpGaD
Testolactone—Testosterone—CYP11A1—uterine cancer	7.91e-05	0.0371	CrCbGaD
Testolactone—Danazol—ESR1—uterine cancer	7.68e-05	0.036	CrCbGaD
Testolactone—Dexamethasone—CYP11A1—uterine cancer	7.65e-05	0.0359	CrCbGaD
Testolactone—CYP19A1—Metapathway biotransformation—AKR1C1—uterine cancer	7.54e-05	0.0166	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	7.45e-05	0.0164	CbGpPWpGaD
Testolactone—Methyltestosterone—CYP19A1—uterine cancer	7.05e-05	0.0331	CrCbGaD
Testolactone—Alopecia—Epirubicin—uterine cancer	6.82e-05	0.00691	CcSEcCtD
Testolactone—Betamethasone—CYP19A1—uterine cancer	6.8e-05	0.0319	CrCbGaD
Testolactone—Erythema—Epirubicin—uterine cancer	6.72e-05	0.00681	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—GPX3—uterine cancer	6.62e-05	0.0146	CbGpPWpGaD
Testolactone—Alopecia—Doxorubicin—uterine cancer	6.31e-05	0.0064	CcSEcCtD
Testolactone—Progesterone—PGR—uterine cancer	6.31e-05	0.0296	CrCbGaD
Testolactone—Ill-defined disorder—Epirubicin—uterine cancer	6.24e-05	0.00632	CcSEcCtD
Testolactone—CYP19A1—Biological oxidations—CYP11A1—uterine cancer	6.23e-05	0.0137	CbGpPWpGaD
Testolactone—Vomiting—Etoposide—uterine cancer	6.22e-05	0.00631	CcSEcCtD
Testolactone—Erythema—Doxorubicin—uterine cancer	6.22e-05	0.0063	CcSEcCtD
Testolactone—Estrone—ESR1—uterine cancer	6.19e-05	0.029	CrCbGaD
Testolactone—CYP19A1—Metapathway biotransformation—CYP11A1—uterine cancer	6.15e-05	0.0135	CbGpPWpGaD
Testolactone—Malaise—Epirubicin—uterine cancer	6.06e-05	0.00614	CcSEcCtD
Testolactone—Nausea—Etoposide—uterine cancer	5.81e-05	0.00589	CcSEcCtD
Testolactone—CYP19A1—Metapathway biotransformation—AKR1C3—uterine cancer	5.81e-05	0.0128	CbGpPWpGaD
Testolactone—Ill-defined disorder—Doxorubicin—uterine cancer	5.77e-05	0.00585	CcSEcCtD
Testolactone—Dexamethasone—PGR—uterine cancer	5.77e-05	0.027	CrCbGaD
Testolactone—Discomfort—Epirubicin—uterine cancer	5.65e-05	0.00573	CcSEcCtD
Testolactone—Malaise—Doxorubicin—uterine cancer	5.61e-05	0.00568	CcSEcCtD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.53e-05	0.0122	CbGpPWpGaD
Testolactone—Oedema—Epirubicin—uterine cancer	5.49e-05	0.00556	CcSEcCtD
Testolactone—Discomfort—Doxorubicin—uterine cancer	5.23e-05	0.0053	CcSEcCtD
Testolactone—Anorexia—Epirubicin—uterine cancer	5.23e-05	0.0053	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—STK11—uterine cancer	5.09e-05	0.0112	CbGpPWpGaD
Testolactone—Oedema—Doxorubicin—uterine cancer	5.08e-05	0.00514	CcSEcCtD
Testolactone—Paraesthesia—Epirubicin—uterine cancer	4.93e-05	0.00499	CcSEcCtD
Testolactone—CYP19A1—FSH signaling pathway—AKT1—uterine cancer	4.86e-05	0.0107	CbGpPWpGaD
Testolactone—Anorexia—Doxorubicin—uterine cancer	4.84e-05	0.0049	CcSEcCtD
Testolactone—Decreased appetite—Epirubicin—uterine cancer	4.77e-05	0.00483	CcSEcCtD
Testolactone—Pain—Epirubicin—uterine cancer	4.69e-05	0.00475	CcSEcCtD
Testolactone—Paraesthesia—Doxorubicin—uterine cancer	4.56e-05	0.00462	CcSEcCtD
Testolactone—Feeling abnormal—Epirubicin—uterine cancer	4.52e-05	0.00458	CcSEcCtD
Testolactone—Decreased appetite—Doxorubicin—uterine cancer	4.41e-05	0.00447	CcSEcCtD
Testolactone—Pain—Doxorubicin—uterine cancer	4.34e-05	0.0044	CcSEcCtD
Testolactone—Feeling abnormal—Doxorubicin—uterine cancer	4.18e-05	0.00424	CcSEcCtD
Testolactone—Testosterone—CYP19A1—uterine cancer	4.09e-05	0.0192	CrCbGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4e-05	0.0088	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4e-05	0.0088	CbGpPWpGaD
Testolactone—Progesterone—ESR1—uterine cancer	3.98e-05	0.0187	CrCbGaD
Testolactone—Dexamethasone—CYP19A1—uterine cancer	3.96e-05	0.0186	CrCbGaD
Testolactone—Vomiting—Epirubicin—uterine cancer	3.49e-05	0.00353	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—ESR1—uterine cancer	3.4e-05	0.00748	CbGpPWpGaD
Testolactone—Nausea—Epirubicin—uterine cancer	3.26e-05	0.0033	CcSEcCtD
Testolactone—Vomiting—Doxorubicin—uterine cancer	3.23e-05	0.00327	CcSEcCtD
Testolactone—Nausea—Doxorubicin—uterine cancer	3.02e-05	0.00306	CcSEcCtD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	2.96e-05	0.00651	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.94e-05	0.00646	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—NDUFB11—uterine cancer	2.46e-05	0.00542	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—SRD5A2—uterine cancer	2.46e-05	0.00542	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.39e-05	0.00527	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.26e-05	0.00497	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.18e-05	0.0048	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.13e-05	0.00468	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—EP300—uterine cancer	2.03e-05	0.00447	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.92e-05	0.00423	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AKR1B1—uterine cancer	1.78e-05	0.00392	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—STAR—uterine cancer	1.78e-05	0.00392	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.63e-05	0.0036	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.45e-05	0.0032	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—POLD1—uterine cancer	1.4e-05	0.00308	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AKR1C1—uterine cancer	1.31e-05	0.00288	CbGpPWpGaD
Testolactone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.23e-05	0.0027	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—RRM2—uterine cancer	1.17e-05	0.00256	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—DCN—uterine cancer	1.13e-05	0.00249	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—CYP11A1—uterine cancer	1.07e-05	0.00235	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AKR1C3—uterine cancer	1.01e-05	0.00222	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—STK11—uterine cancer	7.84e-06	0.00173	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.36e-06	0.00162	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.02e-06	0.00155	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—MTHFR—uterine cancer	5.89e-06	0.0013	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.19e-06	0.00114	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PTEN—uterine cancer	3.28e-06	0.000722	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—EP300—uterine cancer	3.13e-06	0.000688	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—PIK3CA—uterine cancer	2.31e-06	0.000509	CbGpPWpGaD
Testolactone—CYP19A1—Metabolism—AKT1—uterine cancer	1.89e-06	0.000416	CbGpPWpGaD
